The Adrenal Contribution to Androgen Production in Girls During Puberty

Subjects will have blood drawn at 1900 hr for baseline hormone measurements. At 2200 hr each subject will take a single oral dose of dexamethasone at 2200 hr. At 0700 hr the following day, subjects will have a blood sample drawn for hormone measurements. After this blood sample, 0.25 mg adrenocorticotropin hormone (ACTH) will be administered as an iv bolus. At 30 and 60 minutes after Cosyntropin, blood samples will be obtained for repeat hormone measurements.

Inclusion criteria

• Normal CBC (Hemoglobin must be at least 11mg/dl)
• Normal renal and liver function tests (AST& ALT 10-45 IU/L; Albumin 3.3-5 g/dL; Alk phos 30-130 IU/L;
• direct bili <0.2 mg/dL;
• total bili <1.2 mg/dL; total protein 6.0-8.0 g/dL) Normal vital signs including normal blood pressure (pulse 60-100/min, respirations 12-20/min, BP 80/60-130/80)

Exclusion criteria

• Pregnancy
• On oral contraceptives
• On insulin lowering drugs
• On anti-androgens (i.e., spironolactone, flutamide, finasteride, etc)
• On medications that will influence androgen metabolism or clearance
• On medications that will inhibit the cytochrome P450 enzyme system (cimetidine, ketoconazole, etc)
• Subjects with morning cortisol<5 ug/dL will be excluded and asked to see their primary care physician.
• Subjects with 17-OHP>250 ng/dL) will be excluded and asked to see their primary care physician.
• Subject with a history of Cushing syndrome or adrenal insufficiency will be excluded